HRZN News Alert Horizon Technology Finance Corp (HRZN) 14.26

New Post Public Reply Private Reply Replies (0) Message Board

Nov 13, 2014 at 5:31 PM

Horizon Technology Finance Corp (HRZN) 14.26 $HRZN

Horizon Technology Finance's (HRZN) CEO Robert Pomeroy on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Nov 05, 1:16PM CST

HRZN: 14.26 (-0.01)

More on Horizon Technology Finance Q3 results
Seeking Alpha - at Seeking Alpha - Wed Nov 05, 7:50AM CST

HRZN: 14.26 (-0.01)

Horizon Technology Finance beats by $0.01, beats on revenue
Seeking Alpha - at Seeking Alpha - Tue Nov 04, 3:16PM CST

HRZN: 14.26 (-0.01)

Horizon Technology Finance Announces Monthly Distributions for January, February and March 2015 Totaling $0.345 Per Share
GlobeNewswire - Tue Nov 04, 3:06PM CST
Horizon Technology Finance Corporation (Nasdaq:HRZN) ("Horizon"

, a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare information and services, and cleantech industries, announced today that its board of directors declared monthly cash distributions of $0.115 per share payable in each of January, February and March 2015. These monthly distributions, payable as set forth in the table below, total $0.345 per share. Including the monthly distributions declared in the fourth quarter of 2014, Horizon has declared $6.305 per share in cumulative distributions since its October 2010 initial public offering.
HRZN: 14.26 (-0.01)

Horizon Technology Finance Announces Third Quarter 2014 Financial Results
GlobeNewswire - Tue Nov 04, 3:05PM CST
Horizon Technology Finance Corporation (Nasdaq:HRZN) (the "Company" or "Horizon"

, a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare information and services, and cleantech industries, today announced its financial results for the third quarter ended September 30, 2014.
HRZN: 14.26 (-0.01)

Required Returns For BDCs
BDC Buzz - at Seeking Alpha - Tue Nov 04, 3:22AM CST

NMFC: 14.98 (+0.09), PNNT: 10.83 (+0.05), HTGC: 15.52 (-0.45), MAIN: 32.38 (+0.03), TCAP: 22.52 (+0.01), SLRC: 18.30 (-0.43), BKCC: 8.93 (-0.02), FULL: 5.63 (-0.02), TICC: 8.71 (+0.05), SUNS: 15.50 (-0.11), GBDC: 17.38 (-0.07), HRZN: 14.26 (-0.01), PFLT: 14.19 (-0.04), TCPC: 17.12 (-0.01), ARCC: 16.36 (-0.04), FSC: 8.81 (-0.01), MCC: 11.64 (-0.06), KCAP: 7.63 (-0.09), FDUS: 17.07 (+0.17), PSEC: 9.65 (-0.04), FSIC: 10.52 (+0.05)

Horizon Technology Finance Receives SBA "Green Light" Letter
GlobeNewswire - Mon Nov 03, 7:37AM CST
Horizon Technology Finance Corporation (Nasdaq:HRZN) (the "Company" or "Horizon"

, a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare information and services, and cleantech industries, announced the receipt of a "green light" letter from the U.S. Small Business Administration ("SBA"

inviting Horizon to continue its application process to obtain a license to form and operate a Small Business Investment Company ("SBIC"

subsidiary.
HRZN: 14.26 (-0.01)

Buy-Rated Dividend Stocks In The Top 3: KCAP, HRZN, SJT
at The Street - Wed Oct 29, 10:31AM CDT
These 3 dividend stocks are rated a Buy by TheStreet
SJT: 18.44 (-0.63), KCAP: 7.63 (-0.09), HRZN: 14.26 (-0.01)

BDC Market Update Q4 2014: Yield Compression
BDC Buzz - at Seeking Alpha - Tue Oct 28, 5:20AM CDT

NMFC: 14.98 (+0.09), HTGC: 15.52 (-0.45), MAIN: 32.38 (+0.03), TCAP: 22.52 (+0.01), BKCC: 8.93 (-0.02), FULL: 5.63 (-0.02), TICC: 8.71 (+0.05), HRZN: 14.26 (-0.01), PFLT: 14.19 (-0.04), TCPC: 17.12 (-0.01), ARCC: 16.36 (-0.04), FSC: 8.81 (-0.01), MCGC: 3.67 (-0.01), KCAP: 7.63 (-0.09), FDUS: 17.07 (+0.17), PSEC: 9.65 (-0.04), FSIC: 10.52 (+0.05)

Horizon Technology Finance to Announce Third Quarter 2014 Financial Results
eTeligis - Tue Oct 21, 3:16PM CDT
FARMINGTON, CT, United States, via ETELIGIS INC., 10/21/2014 - - Horizon Technology Finance Corporation (NASDAQ: HRZN) (the "Company" or "Horizon"

, a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare information and services, and cleantech industries, announced today that it plans to release financial results for the third quarter ended September 30, 2014 on Tuesday, November 4, 2014, after the close of market trading.
HRZN: 14.26 (-0.01)

Buy-Rated Dividend Stocks In The Top 3: AB, CRT, HRZN
at The Street - Mon Oct 20, 10:30AM CDT
These 3 dividend stocks are rated a Buy by TheStreet
CRT: 26.86 (-0.73), AB: 27.00 (+0.40), HRZN: 14.26 (-0.01)

ZetrOZ, Inc. Announces $5 Million Venture Loan Facility From Horizon Technology Finance to Fuel Expansion Into Amateur Athlete and Chronic Pain Markets
Marketwired - Fri Oct 17, 9:31AM CDT
ZetrOZ, Inc. today announced that it has received a $5 million venture loan facility from Horizon Technology Finance Corporation (NASDAQ: HRZN) ("Horizon"

, a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare information and services, and cleantech industries.
HRZN: 14.26 (-0.01)

Horizon Technology Finance Provides Investment Portfolio Update for Third Quarter 2014
eTeligis - Wed Oct 08, 3:15PM CDT
FARMINGTON, CT, United States, via ETELIGIS INC., 10/08/2014 - - Horizon Technology Finance Corporation (NASDAQ: HRZN) ("Horizon"

, an advanced materials & imaging platform company. InVisage will use the funds primarily for working capital purposes.
HRZN: 14.26 (-0.01)

Argos Therapeutics Enters Into $25 Million Venture Loan Facility Led by Horizon Technology Finance
GlobeNewswire - Tue Sep 30, 8:20AM CDT
Argos Therapeutics, Inc. (Nasdaq:ARGS) ("Argos"

, a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases using its Arcelis(TM) technology platform, today announced that it has entered into a $25 million venture loan led by Horizon Technology Finance Corporation (Nasdaq:HRZN) ("Horizon"

. Argos plans to devote the loan proceeds to the continuing development of AGS-003, the company's lead oncology product candidate, currently being evaluated in the pivotal ADAPT phase 3 clinical trial for the treatment of metastatic renal cell carcinoma (mRCC), and further development of its Arcelis technology platform, including the leasing, build-out and equipping of Argos's planned automated commercial manufacturing facility, and general corporate purposes.
ARGS: 8.57 (-0.04), HRZN: 14.26 (-0.01)

Horizon Technology Finance to Present at the 2014 JMP Securities Financial Services and Real Estate Conference
Marketwire - Tue Sep 23, 3:15PM CDT
Horizon Technology Finance Corporation (NASDAQ: HRZN) ("Horizon"

, a leading specialty finance company that provides secured loans to venture capital and private equity backed development-stage companies in the technology, life science, healthcare information and services, and cleantech industries, today announced that Robert D. Pomeroy, Jr., Chairman and Chief Executive Officer, and Christopher M. Mathieu, Chief Financial Officer, are scheduled to present and participate in one-on-one investor meetings at the 2014 JMP Securities Financial Services and Real Estate Conference. The conference will be held at The St. Regis in New York, with the presentation at 1:00 p.m. ET on Tuesday, September 30, 2014. The accompanying slide presentation will be available in the "Events & Presentations" section of Horizon's website, www.horizontechnologyfinancecorp.com/events.cfm.
HRZN: 14.26 (-0.01)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Metropolitan at The 9 Unveils Major Renovation in 2026

A Cleveland Gem Gets a Makeover Alright, listen up—Metropolitan at The 9 in Cleveland has undergone a massive facelift. We're talking about a complete overhaul of every single one of its 156 guestrooms and suites, new elevators, a refreshed lobby, and a reimagined Ledger Bar. Details and Delights in Every Corner Let's dig into the nitty-gritty. Guests are walking into...

Century Communities Unveils New Homes Near Austin

New Opportunities in the Lone Star State Century Communities, Inc. (NYSE: CCS) is cranking up the heat in the real estate market with their latest attraction—Crosswinds in Kyle, Texas. This isn't just another cookie-cutter development; it's packing in excitement with a grand opening on October 28. From model home tours to early-bird savings, they're pulling out all the...

CPSC's Management Overhaul: Progress or Just Polishing?

The Tangled Web of Bureaucracy Ah, the Consumer Product Safety Commission—CPSC for short. It's like the Secretariat of product safety, but often knee-deep in old problems. Over the years, hearing about their challenges is like flipping through a well-worn playbook. But now, the talk is all about a fresh page under Acting Chairman Peter A. Feldman. The watchdog in...

Post University Expands with New Tech and Health Degrees

If you're looking to invest in an education with promising payoffs, you might look into what's cooking over at Post University. They've just dropped a bombshell of new programs sure to get some attention from tech heads and health nuts alike, and I can't help but think there's potential brewing here. New Academic Paths Emerge Post University isn't resting on its...

Cumberland Pharmaceuticals Eyes NDA for Ifetroban in DMD

Rolling the Dice with Ifetroban There's a buzz in the air around Cumberland Pharmaceuticals as they gear up to tackle one of medicine's stubborn giants, Duchenne muscular dystrophy (DMD). They plan to file a New Drug Application (NDA) with the FDA for ifetroban, aiming to treat the cardiomyopathy plaguing many DMD sufferers. Folks who’ve watched Cumberland (NASDAQ:CPIX)...

Natural Field Reinvents Supplement Delivery at SupplySide

Pioneering New Frontiers in Supplement Delivery Sometimes you can taste the winds of change in your morning coffee, and this time it’s in the world of dietary supplements. SupplySide Global 2026 is shaking up the scene, folks, and Natural Field Co., Ltd. is leading that charge with some pioneering approaches that might just redefine how we gulp our health aids. Beyond...

Costa Rican Firms Target Aerospace Supply Chain Gains

Today's spotlight swings on a gutsy move by 10 Costa Rican aerospace companies hustling for a foothold on the global stage. These folks aren't just sitting back; they're throwing their hats in the ring at the NBAA-BACE shindig down in the neon glare of Las Vegas, aiming to muscle into the aerospace supply chain — a cold, hard leap that's a mix of grit and ambition....

LuminoCity Expands with B2B Entertainment Showcase

Big Lights, Immersive Action In an age where entertainment must be larger-than-life, LuminoCity seems to have figured out how to transform the ordinary into the extraordinary. The folks over at LuminoCity Festival have rolled out a strategy to supercharge their business-to-business (B2B) offerings, aiming to bring immersive entertainment solutions to parks, zoos, and...

PG&E Halts Service; Groups Demand Regulatory Action

Pending Storm Over PG&E's Service Delays It's rare that you hear a utility company flat-out say it can't afford to keep the lights on. Yet here we are, staring down the barrel of some unsettling news for 25,000 PG&E customers. They've been warned they might cool their heels for an extra six months before their service is up and running. As if that's not dicey enough, $2...

XCMG Climbs Fortune China 500: Strengthens Global Edge

XCMG's Ascent on the Fortune China 500 When it comes to scaling new heights, XCMG Machinery is clearly in the driver's seat, roaring up the Fortune China 500 to claim the 202nd spot, leaping ten ranks from last year. While others may coast, XCMG's trajectory is anything but idle, retaining its crown among Chinese construction machinery titans. The recent summit in Chengdu...